G01N 2333/5756
Prolactin
G01N2333/5756 (Prolactin) appears on 12 US grants and 25 published applications in this corpus.
Search patents in G01N- Granted patents
- 12
- Published applications
- 25
- Assignees
- 23
- Inventors
- 76
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 3 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 5 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 0 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods, assays and systems for detection of a target analyte21 Apr 2026US 12,607,589 B2Sorrento Therapeutics, Inc.
- Identification of cancer protein biomarkers using proteomic techniques1 Jan 2019US 10,168,334 B2Yale University
- Identification of cancer protein biomarkers using proteomic techniques18 Oct 2016US 9,470,688 B2Yale University
- Identification of cancer protein biomarkers using proteomic techniques10 Mar 2015US 8,975,379 B2Yale University
- Compositions and methods for visualizing and eliminating cancer stem cells17 Jun 2014US 8,754,035 B2Oncolix, Inc.
- Composition, aqueous solution of endocrine protein, adsorption inhibitor, method for suppressing adsorption of endocrine protein, method for measuring amount of endocrine protein, and reagent kit for measuring endocrine protein29 Jan 2026US 2026/0029419 A1FUJIFILM Corporation
- Biomarkers8 Jan 2026US 2026/0009802 A1Oxford University Innovation Limited
- Methods, Assays and Systems for Detection of a Target Analyte12 Sep 2024US 2024/0302317 A1Virex Health, Inc.
- Biomarker pairs and triplets for predicting preterm birth8 Aug 2024US 2024/0264170 A1Sera Prognostics, Inc.
- Device for simultaneous and rapid determination in saliva of the fertility hormones estradiol, progesterone, luteinizing hormone and prolactin20 Jan 2022US 2022/0018800 A1
Most cited
By later US patents
- Methods for the determination and adjustment of prolactin daily rhythms37US 5,830,895 ABoard of Supervisors of Louisiana State University and Agricultural and Mechanical College · 1998
- Identification of cancer protein biomarkers using proteomic techniques20US 7,666,583 B2Yale University · 2010
- Screening for gestational disorders12US 7,323,346 B2Harvard University · 2008
- Composition and method for modulating somatolactogenic function9US 6,867,187 B2The Trustees of the University of Pennsylvania · 2005
- Method of assay normalized with non-antigen calibrator8US 5,312,729 AAres-Serono Research & Development Limited Partnership · 1994